Sociodemographic Risk Factors to Disease Control in Children with Diabetes

Overstreet, Stacy; Holmes, Clarissa S.; Dunlap, William P.; Frentz, Johnette

doi:10.1002/(sici)1096-9136(199702)14:2<153::aid-dia318>3.0.co;2-k

Cited by 52 publications

(45 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Administrative claims data were the most common sources of primary ADE detection, used in 37.5 % (15/40) of studies [9][10][11][12][13][14][15][16][17][18][19][20][21][22][23]. Chart review was used as a primary ADE detection method in 35 % (14/40) of studies [8,[24][25][26][27][28][29][30][31][32][33][34][35][36], and survey or patient/ parent report was used in 27.5 % (11/40) of the studies [27,32,33,[37][38][39][40][41][42][43][44]. Direct documentation by research staff was used by three studies (7.5 %) [45][46][47].…”

Section: Resultsmentioning

confidence: 99%

“…Eight studies analyzed ADEs in the inpatient setting, eight in the outpatient setting, and two in the emergency department. The three studies that did not demonstrate a racial or ethnic disparity all analyzed patients in the outpatient setting, detected ADEs via survey or report, and had relatively small sample sizes of less than 600 participants [39,41,42].…”

Section: Diabetes Agents-related Adverse Drug Eventsmentioning

confidence: 94%

See 1 more Smart Citation

Racial and Ethnic Disparities in Adverse Drug Events: A Systematic Review of the Literature

Baehr

Peña

2015

J. Racial and Ethnic Health Disparities

View full text Add to dashboard Cite

The 2014 National Action Plan for Adverse Drug Event Prevention has recognized adverse drug events (ADEs) as a national priority in order to facilitate a nationwide reduction in patient harms from these events. Throughout this effort, it will be integral to identify populations that may be at particular risk in order to improve care for these patients. We have undertaken a systematic review to evaluate the evidence regarding racial or ethnic disparities in ADEs with particular emphasis on anticoagulants, diabetes agents, and opioids due to the clinical significance and preventability of ADEs associated with these medication classes. From an initial search yielding 3302 studies, we identified 40 eligible studies. Twenty-seven of these included studies demonstrated the presence of a racial or ethnic disparity. There was no consistent evidence for racial or ethnic disparities in the eight studies of ADEs in general. Asians were most frequently determined to be at higher risk of anticoagulant-related ADEs, and black patients were most frequently determined to be at higher risk for diabetes agents-related ADEs. Whites were most frequently identified as at increased risk for opioid-related ADEs. However, few of these studies were specifically designed to evaluate racial or ethnic disparities, lacking a standardized approach to racial/ethnic categorization as well as control for potential confounders. We suggest the need for targeted interventions to reduce ADEs in populations that may be at increased risk, and we suggest strategies for future research.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Diabetes Agents-related Adverse Drug Eventsmentioning

confidence: 94%

Racial and Ethnic Disparities in Adverse Drug Events: A Systematic Review of the Literature

Baehr

Peña

2015

J. Racial and Ethnic Health Disparities

View full text Add to dashboard Cite

show abstract

“…Likewise, youths of lower SES scored higher on the BGMC questionnaire than youths of higher SES. Notably, in our sample, SES tracked with minority status in a manner similar to that seen in previous research findings (26). Despite the statistically significant differences in BGMC survey scores by SES and sex, clinically significant differences in BGMC survey scores are more apparent at the extremes of the distribution.…”

Section: Relationship Between Bgm Affect and Glycemic Controlmentioning

confidence: 99%

The Blood Glucose Monitoring Communication Questionnaire

et al. 2004

View full text Add to dashboard Cite

OBJECTIVE -The aim of this study was to present the psychometric properties of a new tool for evaluating affective response to blood glucose monitoring (BGM) in youths with type 1 diabetes and their parents. RESULTS -Youth and parent BGMC questionnaires had acceptable internal consistency (youth, ␣ ϭ 0.77; parent, ␣ ϭ 0.82) and 1-year test-retest reliability (youth, r ϭ 0.60; parent, r ϭ 0.80). Higher BGMC questionnaire scores (indicating more negative affect) showed a strong association with higher levels of diabetes-specific family conflict (youth, r ϭ 0.33; parent, r ϭ 0.44) and poorer health-related psychosocial quality of life (youth, r ϭ Ϫ0.50; parent, r ϭ Ϫ0.42). Higher BGMC questionnaire scores were also associated with poorer glycemic control (youth, r ϭ 0.28; parent, r ϭ 0.20), even when the effects of diabetes-specific family conflict and psychosocial quality of life were controlled. Youths with BGMC questionnaire scores in the upper quartile had A1c values 1 percentage point higher (9.1%) than youths with scores in the lowest quartile (8.0%). RESEARCH DESIGN AND METHODSCONCLUSIONS -The BGMC questionnaires have strong psychometric properties and are convenient measures of affect specific to BGM. Further, BGM affect is associated with glycemic outcomes and may provide a unique contribution to factors associated with glycemic control in youths. Diabetes Care 27:2610 -2615, 2004D uring the past two decades, blood glucose monitoring (BGM) has been established as an important component of type 1 diabetes management. Findings from the Diabetes Control and Complications Trial and other studies stress the necessity of BGM for intensive treatment of diabetes, largely because of the relationship between BGM and glycemic outcomes in populations with type 1 and type 2 diabetes and the link between hyperglycemia and long-term complications (1-5). Further, in pediatric and adolescent patients with type 1 diabetes, a strong association exists between adherence to BGM and glycemic control; a higher frequency of BGM is associated with lower A1c levels (6 -8). Thus, it is not surprising that the American Diabetes Association, in its clinical practice guidelines (9), stresses the importance of frequent BGM for intensive treatment of diabetes.Despite an emphasis on intensive diabetes management, which includes frequent BGM, glycemic control remains suboptimal in pediatric and adolescent populations. Although biological and social changes in youths impact glycemic control in direct and in indirect ways (10), the demands of diabetes management can promote negative feelings in family members. Diabetes-specific family conflict is consistently identified as having a negative impact on adherence to diabetes tasks and glycemic outcomes (11-13) and may arise from either parental perception of inadequate monitoring frequency or the child's inability to achieve or maintain near-normal blood glucose levels. Thus, conflict around BGM, such as parental nagging or criticism, may serve to promote negative feelings in the youth directed...

show abstract

“…With few exceptions (Baumer et al 1998;Chaturvedi et al 1998), however, all of these investigations are limited by their use of unadjusted mean or median HbA1c levels for their comparisons across social groups. In contrast to the British fi ndings, research elsewhere in Europe and the USA demonstrates an inverse association between HbA1c levels and SES indicators (Chaturvedi et al 1996;Hjelm et al 1996;Overstreet et al 1997;Mühlhauser et al 1998;Saaddine et al 2002). Nearly all of these studies (Chaturvedi et al 1996;Hjelm et al 1996;Mühlhauser et al 1998;Saaddine et al 2002) base their analyses on regression models and adjust as a minimum for age, sex and diabetes duration.…”

mentioning

confidence: 99%